Nuveen Asset Management, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 165 filers reported holding NEVRO CORP in Q2 2019. The put-call ratio across all filers is 5.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$4,327,671
-26.2%
225,165
-2.4%
0.00%0.0%
Q2 2023$5,866,122
+70220.3%
230,7680.0%0.00%
-33.3%
Q1 2023$8,342
+25.3%
230,768
+37.3%
0.00%0.0%
Q4 2022$6,657
-99.9%
168,121
+26.4%
0.00%0.0%
Q3 2022$6,200,000
+3.2%
133,049
-3.0%
0.00%
+50.0%
Q2 2022$6,010,000
-36.8%
137,135
-3.3%
0.00%
-33.3%
Q1 2022$9,509,000
+12.1%
141,831
+35.8%
0.00%0.0%
Q4 2021$8,486,000
-85.1%
104,477
-78.7%
0.00%
-83.3%
Q3 2021$57,090,000
-36.2%
490,549
-9.1%
0.02%
-33.3%
Q2 2021$89,518,000
+25.6%
539,943
+5.7%
0.03%
+17.4%
Q1 2021$71,271,000
-15.5%
510,896
+4.8%
0.02%
-20.7%
Q4 2020$84,361,000
+50.4%
487,357
+21.1%
0.03%
+31.8%
Q3 2020$56,083,000
+24.4%
402,605
+6.7%
0.02%
+22.2%
Q2 2020$45,089,000
+98.9%
377,407
+66.4%
0.02%
+63.6%
Q1 2020$22,671,000
-30.4%
226,754
-18.2%
0.01%
-8.3%
Q4 2019$32,583,000
+81.2%
277,206
+32.5%
0.01%
+71.4%
Q3 2019$17,980,000
-33.0%
209,137
-49.4%
0.01%
-36.4%
Q2 2019$26,818,000
+2696.5%
413,667
+2878.6%
0.01%
+83.3%
Q4 2017$959,000
-90.9%
13,888
-88.0%
0.01%
-91.3%
Q3 2017$10,520,000
+698.8%
115,752
+554.0%
0.07%
+762.5%
Q2 2017$1,317,000
-16.6%
17,700
+5.1%
0.01%
-11.1%
Q1 2017$1,579,000
+26.6%
16,847
-1.8%
0.01%
+50.0%
Q4 2016$1,247,000
+2.9%
17,159
+47.7%
0.01%
-14.3%
Q3 2016$1,212,000
-3.0%
11,615
-31.4%
0.01%
-12.5%
Q2 2016$1,250,00016,9430.01%
Other shareholders
NEVRO CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,446,333$82,441,0004.44%
Asymmetry Capital Management, L.P. 31,379$1,789,0001.65%
TIRSCHWELL & LOEWY INC 194,470$11,085,0001.38%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 673,480$38,388,0001.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 525,040$29,927,0001.07%
Orbimed Advisors 1,357,691$77,388,0000.93%
Sio Capital Management, LLC 45,091$2,570,0000.88%
PURA VIDA INVESTMENTS, LLC 60,000$3,420,0000.72%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 159,800$9,109,0000.62%
Endurant Capital Management LP 24,171$1,378,0000.61%
View complete list of NEVRO CORP shareholders